Alnylam Pharmaceuticals

organization

biopharmaceutical company

History Claim
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Alnylam Pharmaceuticals
Image: Wikimedia Commons

Handles

Social

Web

2 external identifiers

Something wrong with this entry? Report it.